Intellipharmaceutics International Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Intellipharmaceutics International Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2020 to Q3 2023.
  • Intellipharmaceutics International Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending August 31, 2023 was $820.000.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $820 Aug 31, 2023 6-K 2023-10-16
Q2 2023 $2.83K May 31, 2023 6-K 2023-09-26
Q1 2023 $6.07K Feb 28, 2023 6-K 2023-09-26
Q4 2022 $10.4K Nov 30, 2022 20-F/A 2024-02-06
Q3 2021 $787 Aug 31, 2021 6-K 2021-10-15
Q2 2021 $2.85K May 31, 2021 6-K 2021-07-15
Q1 2021 $6.87K Feb 28, 2021 6-K 2021-04-14
Q4 2020 $6.79K Nov 30, 2020 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.